Clinical Trials
4 trialsNCT03710564 2023-01-30
MERLIN
Novartis
Phase 3 Terminated
NCT00794417 2020-12-10
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma
Regeneron Pharmaceuticals
Phase 1/2 Terminated
NCT00574275 2016-06-07
VANILLA
Sanofi
Phase 3 Terminated
NCT01955629 2016-04-18
AMOR
Sanofi
Phase 1/2 Terminated